These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 24673427)
1. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database. Kuhn A; Sigges J; Biazar C; Ruland V; Patsinakidis N; Landmann A; Amler S; Bonsmann G; Br J Dermatol; 2014 Sep; 171(3):571-9. PubMed ID: 24673427 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Biazar C; Sigges J; Patsinakidis N; Ruland V; Amler S; Bonsmann G; Kuhn A; Autoimmun Rev; 2013 Jan; 12(3):444-54. PubMed ID: 23000206 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus. Sigges J; Biazar C; Landmann A; Ruland V; Patsinakidis N; Amler S; Bonsmann G; Kuhn A; Autoimmun Rev; 2013 May; 12(7):694-702. PubMed ID: 23220353 [TBL] [Abstract][Full Text] [Related]
4. The impact of the EUSCLE Core Set Questionnaire for the assessment of cutaneous lupus erythematosus. Kuhn A; Patsinakidis N; Bonsmann G Lupus; 2010 Aug; 19(9):1144-52. PubMed ID: 20693209 [TBL] [Abstract][Full Text] [Related]
5. Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Kuhn A; Kuehn E; Meuth AM; Haust M; Nyberg F; Werth V; Ruzicka T; Schmitt V; Bonsmann G; Autoimmun Rev; 2009 Jul; 8(8):702-12. PubMed ID: 19232553 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI. Bein D; Kuehn E; Meuth AM; Amler S; Haust M; Nyberg F; Sauerland C; Luger TA; Bonsmann G; Kuhn A J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):652-9. PubMed ID: 20849444 [TBL] [Abstract][Full Text] [Related]
7. Impact of smoking in cutaneous lupus erythematosus. Piette EW; Foering KP; Chang AY; Okawa J; Ten Have TR; Feng R; Werth VP Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815 [TBL] [Abstract][Full Text] [Related]
8. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus. Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966 [TBL] [Abstract][Full Text] [Related]
9. A database analysis of cutaneous lupus erythematosus with the EUSCLE Core Set Questionnaire. Meuth AM; Amler S; Haust M; Bein D; Sauerland C; Köpcke W; Bonsmann G; Nyberg F; Kuhn A Acta Derm Venereol; 2010 Jul; 90(4):386-94. PubMed ID: 20574604 [TBL] [Abstract][Full Text] [Related]
10. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking. Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751 [TBL] [Abstract][Full Text] [Related]
11. Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. Chasset F; Francès C; Barete S; Amoura Z; Arnaud L J Am Acad Dermatol; 2015 Apr; 72(4):634-9. PubMed ID: 25648824 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain. Arévalo-Bermúdez MDP; Paradela S; Balboa-Barreiro V; Fonseca E Lupus; 2020 Aug; 29(9):1021-1030. PubMed ID: 32539659 [TBL] [Abstract][Full Text] [Related]
13. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. Jewell ML; McCauliffe DP J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400 [TBL] [Abstract][Full Text] [Related]
14. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. Rahman P; Gladman DD; Urowitz MB J Rheumatol; 1998 Sep; 25(9):1716-9. PubMed ID: 9733451 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological characteristics of patients with cutaneous lupus erythematosus. Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922 [TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus. Ezra N; Jorizzo J Clin Exp Dermatol; 2012 Jun; 37(4):327-34. PubMed ID: 22582908 [TBL] [Abstract][Full Text] [Related]
17. Natural history of disease activity and damage in patients with cutaneous lupus erythematosus. Ker KJ; Teske NM; Feng R; Chong BF; Werth VP J Am Acad Dermatol; 2018 Dec; 79(6):1053-1060.e3. PubMed ID: 29969701 [TBL] [Abstract][Full Text] [Related]
18. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Schmitt V; Meuth AM; Amler S; Kuehn E; Haust M; Messer G; Bekou V; Sauerland C; Metze D; Köpcke W; Bonsmann G; Kuhn A Br J Dermatol; 2010 Jan; 162(1):64-73. PubMed ID: 19712116 [TBL] [Abstract][Full Text] [Related]
19. Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Kuhn A; Meuth AM; Bein D; Amler S; Beissert S; Böhm M; Brehler R; Ehrchen J; Grundmann S; Haust M; Ruland V; Schiller M; Schulz P; Ständer S; Sauerland C; Köpcke W; Luger TA; Bonsmann G Br J Dermatol; 2010 Jul; 163(1):83-92. PubMed ID: 20394621 [TBL] [Abstract][Full Text] [Related]
20. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Grönhagen CM; Fored CM; Granath F; Nyberg F Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]